One of the major roadblocks in treating diseases affecting the brain lies in delivering drugs across the blood-brain barrier. From nanoparticles to neurotropic viruses and exosomes to shark antibodies, scientists and engineers develop new strategies to bring effective therapeutics into this immunologically privileged space. In this seminar, experts will discuss interventions that target the blood-brain barrier to facilitate drug delivery to the brain.
Topics to be covered
Speakers
Zhenpeng Qin, PhD
Associate Professor, Department of Mechanical Engineering, Bioengineering
Center for Advanced Pain Studies (CAPS), University of Texas at Dallas
Adjunct Faculty of Surgery, University of Texas Southwestern Medical Center
Olaf van Tellingen, PhD
Group Leader,
Division of Pharmacology,
Netherlands Cancer Institute,
Amsterdam
Costas Arvanitis, PhD
Assistant Professor, G. W. Woodruff School of Mechanical Engineering and W. H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University
Graeme F. Woodworth, MD
Professor and Chair, Department of Neurosurgery, University of Maryland School of Medicine
Director, Brain Tumor Program and Translational Therapeutics Research Group, Greenebaum Comprehensive Cancer Center, University of Maryland
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2021 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy